Expertise in
17
conditions

Sergio A. Harari

Milan, IT 
Expertise in
17
conditions
Milan, IT 

Overview

Sergio Harari practices practicing medicine in Milan, Italy.

Mr. Harari is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lymphangioleiomyomatosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, and Lung Transplant.

He is actively involved in clinical research, co-authoring 200 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Milan, Italy
Other Locations
Cura, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Pilot Study of Nintedanib for LymphAngioleioMyomatosis (LAM)
A Pilot Study of Nintedanib for LymphAngioleioMyomatosis (LAM)
Enrollment Status: Completed
Publish Date: September 28, 2022
Intervention Type: Drug
Study Drug: Nintedanib
Study Phase: Phase 2
View 2 Less Clinical Trials

200 Total Publications

Transcriptional evidence of neuroendocrine cell plasticity beyond histological boundaries in lung neuroendocrine neoplasms: an in-silico analysis suggesting a progression model.
Transcriptional evidence of neuroendocrine cell plasticity beyond histological boundaries in lung neuroendocrine neoplasms: an in-silico analysis suggesting a progression model.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 08, 2026

Frequently Asked Questions about Sergio A. Harari

Is Sergio A. Harari a top-rated expert for Lymphangioleiomyomatosis?

MediFind is an objective health platform that identifies experts based on real-world data. Sergio A. Harari is classified as an Elite expert for Lymphangioleiomyomatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sergio A. Harari participate in research or clinical trials?

Yes. Sergio A. Harari has published 200 articles and abstracts on conditions like Lymphangioleiomyomatosis. You can view a list of Sergio A. Harari's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Harari's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile